Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine Coppinger

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Genetics|August 15, 2014
The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspectiveGary J Latham, Justine Coppinger, Andrew G Hadd, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 3, 2007
The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the futureLisa G Shaffer, Bassem A Bejjani, Beth Torchia, et al.
Prenatal Diagnosis|October 2, 2009
Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarrayJustine Coppinger, Sarah Alliman, Allen N Lamb, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Early Alzheimer's diagnosis: U.S. primary care physicians and use of blood biomarkersJeffrey M Burns, Susan Alford, Justine Coppinger, et al.
Prenatal Diagnosis|October 7, 2010
Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal settingIdit Maya, Bella Davidov, Liron Gershovitz, et al.
Prenatal Diagnosis|July 23, 2008
Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimensLisa G Shaffer, Justine Coppinger, Sarah Alliman, et al.
Journal of Neurodevelopmental Disorders|July 7, 2011
Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplicationsJill A Rosenfeld, Justine Coppinger, Bassem A Bejjani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSusan Alford, Sheena K Aurora, Justine Coppinger, et al.
NPJ Dementia|September 8, 2025
Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairmentJustine Coppinger, Tim West, Kris M Kirmess, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Independent validation of the PrecivityAD2<sup>™</sup> blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairmentJustine Coppinger, Tim West, Kris M Kirmess, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Genetics|August 15, 2014
The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspectiveGary J Latham, Justine Coppinger, Andrew G Hadd, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 3, 2007
The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the futureLisa G Shaffer, Bassem A Bejjani, Beth Torchia, et al.
Prenatal Diagnosis|October 2, 2009
Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarrayJustine Coppinger, Sarah Alliman, Allen N Lamb, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Early Alzheimer's diagnosis: U.S. primary care physicians and use of blood biomarkersJeffrey M Burns, Susan Alford, Justine Coppinger, et al.
Prenatal Diagnosis|October 7, 2010
Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal settingIdit Maya, Bella Davidov, Liron Gershovitz, et al.
Prenatal Diagnosis|July 23, 2008
Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimensLisa G Shaffer, Justine Coppinger, Sarah Alliman, et al.
Journal of Neurodevelopmental Disorders|July 7, 2011
Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplicationsJill A Rosenfeld, Justine Coppinger, Bassem A Bejjani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSusan Alford, Sheena K Aurora, Justine Coppinger, et al.
NPJ Dementia|September 8, 2025
Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairmentJustine Coppinger, Tim West, Kris M Kirmess, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Independent validation of the PrecivityAD2<sup>™</sup> blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairmentJustine Coppinger, Tim West, Kris M Kirmess, et al.
Pageof 3